EN
HI
Summary
As of 25 Sep, 2026, Glaxosmithkline Pharmaceuticals stock price is ₹2829.2. During the trading session, the stock has moved between an intraday low of ₹2815.00 and an intraday high of ₹2880.00. Over the last 52 weeks, Glaxosmithkline Pharmaceuticals has traded between ₹2088.10 and ₹3120.70.
The stock has recorded a trading volume of 17,953 shares,. Its Average Traded Price (ATP) is ₹2847.60, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2829.20.
Glaxosmithkline Pharmaceuticals has an upper circuit limit of ₹3452.20 and a lower circuit limit of ₹2301.60. The total value traded stands at ₹5.11 CR, and the delivery percentage for the day is 72.28%.
The stock is currently traded with a market lot size of 1. Glaxosmithkline Pharmaceuticals also offers a dividend yield of 1.98%.
Glaxosmithkline Pharmaceuticals Share Price Chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
17953.00
Market Cap
47928.36 CR
LTQ@LTP
1@2829.20
ATP
2847.6
Var Margin
15.28 %
Circuit Range
2301.6-3452.2
Delivery %
72.28 %
Value
5.11 CR
ASM/GSM
No
Market Lot
1
Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
45.62
P/B Ratio
19.33
Div. Yield
1.98
Sector P/E
38.55
Sector P/B
3.7
Sec. Div. Yield
0.51
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2879.6
Resistance
First Resistance
2919.3
Second Resistance
2961.7
Third Resistance
3001.4
Support
First Support
2837.2
Second Support
2797.5
Third Support
2755.1
Glaxosmithkline Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 24 2026 | 2874 | 2829.2 | -1.66% | 2880 | 2815 |
| Wed Sep 23 2026 | 2859.6 | 2876.89 | 0.11% | 2922 | 2839.89 |
| Tue Sep 22 2026 | 2862.69 | 2873.6 | 0.37% | 2880.89 | 2840 |
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
| 2024-10-29 | Quarterly Results & Interim Dividend |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
GlaxoSmithKline Pharmaceuticals announced the outcome of its postal ballot. Shareholders approved the appointment of Ms. Karine J F Natland as Non-Executive Director and the re-appointment of Mr. Bhushan Akshikar as Managing Director with overwhelming support.
Sep 15 2026 12:49:29
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
GlaxoSmithKline Pharmaceuticals announced the outcome of its postal ballot. Shareholders approved the appointment of Ms. Karine J F Natland as Non-Executive Director and the re-appointment of Mr. Bhushan Akshikar as Managing Director with overwhelming support.
Sep 15 2026 12:47:40
Read More
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Alkem Laboratories Ltd.
5326.00
-91.50 (1.69%)
Biocon Ltd.
387.00
-8.00 (2.03%)
Abbott India Ltd.
26860.00
-75.00 (0.28%)
Ipca Laboratories Ltd.
1997.10
34.50 (1.76%)
Anthem Biosciences Ltd.
885.60
3.70 (0.42%)
Gland Pharma Ltd.
2897.40
-12.80 (0.44%)
Ajanta Pharma Ltd.
3539.50
-28.60 (0.80%)
Global Health Ltd.
1506.20
10.10 (0.68%)
Narayana Hrudayalaya Ltd.
1877.70
-41.60 (2.17%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2829.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 45.62. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 19.33. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 38.55 & 3.7 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 47928.36 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3120.70 & 2088.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLAXO
